Use access key #2 to skip to page content.
$46.51 1.24 (2.74%)
5/16/2008 4:00 PM

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

CAPS Rating:
*****

A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating TEVA

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

929 Outperforms
36 Underperforms
 

All-Stars

291 Outperforms
6 Underperforms
 

Wall Street

8 Outperforms
1 Underperforms
 

Players bullish on TEVA are also bullish on:

Players bearish on TEVA are also bearish on:

Ticker Tags

Israel (23), Nasdaq 100 (99), Drug Manufacturers - Other (105), Drugs - Generic (14), Large Cap (467)
Suggest a tag

Teva Pharmaceutical Industries Ltd (ADR) At A Glance

Current Price: $46.51
Last Trade Time: 5/16/2008 4:00 PM
Open: $45.54
Previous Close: $45.27
Daily Range: $45.34 - $46.64
52-Week Range: $38.42 - $50.00
Volume: 5,906,363
Market Cap: $36.73B
P/E Ratio: 16.34
Compare Our Special Broker Offers!

Stock Trends

TEVA VS S&P 500 (SPY)

TEVA 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for TEVA

More Headlines...

Top Bull Pitch

Recs

3

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Avatar pennysplants (98.62) Submitted: 1/14/08 5:49 PM

I had previously put TEVA on auto-pilot ... and gained 30+ points (15 months) in the process. But, now, I'm not so sure.

I'm downgrading my position until I complete more DD on emerging competitors. And there are a few !!!!

An A+++ legal team ... alone ... does NOT a global generic pharma / global...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Avatar dwot (99.96) Submitted: 3/28/07 12:11 PM

$28 billion market cap and a P/E of 53 and reduced profitability over the past year...





No thank you.

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 198 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (TEVA)

Avatar Randian (< 20) Submitted: 5/15/08 2:46 AM : Outperform Start Price: $45.17 TEVA Score: 1.92

Teva is the world's biggest generic drug company. They are usually first with a generic when an important drug goes off patent. Any time you see analysts' talking about "bad news" for Pfizer or Merck et al about brand name drugs nearing the end of patent protection, notice the invisible ink between the lines. That is the "good news" for TEVA.





Also, if the US gets a Democrat in '08 look for any universal healthcare initiative to use the US Veteran's Administration as a model. That model includes an aggressive push toward generic drugs. Rx drug costs are a major fraction of overall healthcare costs.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar bluedome (89.76) Submitted: 5/14/08 7:29 PM : Outperform Start Price: $45.17 TEVA Score: 1.92

numbers look good


generics

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar apalme3 (< 20) Submitted: 5/07/08 5:59 PM : Outperform Start Price: $45.30 TEVA Score: 0.62

Huge pipeline of generic drugs

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar elad234 (63.62) Submitted: 5/07/08 2:58 AM : Outperform Start Price: $46.39 TEVA Score: -0.24

exepcted growh in the coming 2 years, this is the largest company in israel in the pharamcology industry, and one of the biggest players around.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar ADertsakian (48.61) Submitted: 5/02/08 7:35 PM : Outperform Start Price: $47.32 TEVA Score: -2.86

Excellent pharmaceutical stock. A generic drug manufacturer based out of Israel. Has been getting approvals left and right for generics. Since Medicare Part D started in January of 06 more and more insurance companies are removing brand name drugs from their formulary's and forcing pharmacy use generics. This is a good solid long term investment.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 198 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBofASec 93.49 12/18/07 Outperform NS $44.05+5.58%-2.35%+7.93
TrackFBR 86.53 10/31/07 Outperform NS $43.54+6.83%-7.35%+14.18
TrackBearStearns 93.23 07/09/07 Outperform NS $40.99+13.48%-6.61%+20.09
TrackCreditSuiss 94.46 06/06/07 Outperform NS $39.22+18.57%-6.70%+25.28
TrackUBS 93.41 03/23/07 Outperform NS $36.97+25.80%-0.45%+26.25
TrackFTNMidwest < 20 03/06/07 Outperform NS $35.49+31.05%+2.77%+28.28
TrackScottBleier < 20 12/16/06 Outperform 3M $31.74+46.54%+0.22%+46.32
TrackGaryBSmith 25.77 08/04/06 Outperform 3W $33.88+37.27%+11.28%+25.99
TrackJimCramer 80.65 06/23/06 Underperform 3W $31.71+46.68%+14.84%-31.84

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners